Chuan‐Hang Yu

2.7k total citations
89 papers, 1.8k citations indexed

About

Chuan‐Hang Yu is a scholar working on Periodontics, Oral Surgery and Molecular Biology. According to data from OpenAlex, Chuan‐Hang Yu has authored 89 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Periodontics, 20 papers in Oral Surgery and 19 papers in Molecular Biology. Recurrent topics in Chuan‐Hang Yu's work include Oral Health Pathology and Treatment (27 papers), Oral and Maxillofacial Pathology (17 papers) and Cancer-related molecular mechanisms research (11 papers). Chuan‐Hang Yu is often cited by papers focused on Oral Health Pathology and Treatment (27 papers), Oral and Maxillofacial Pathology (17 papers) and Cancer-related molecular mechanisms research (11 papers). Chuan‐Hang Yu collaborates with scholars based in Taiwan, United States and Japan. Chuan‐Hang Yu's co-authors include Cheng‐Chia Yu, Chun‐Pin Chiang, Ming‐Yung Chou, Yu‐Chao Chang, Shih‐Jung Cheng, Fang‐Wei Hu, Hung‐Pin Lin, Yi‐Wen Liao, Chih‐Yu Peng and Yi‐Ping Wang and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Biological Macromolecules.

In The Last Decade

Chuan‐Hang Yu

83 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chuan‐Hang Yu Taiwan 28 613 577 435 336 335 89 1.8k
Mário Pérez‐Sayáns Spain 28 1.1k 1.8× 501 0.9× 567 1.3× 361 1.1× 477 1.4× 178 2.6k
Raghu Radhakrishnan India 24 574 0.9× 361 0.6× 283 0.7× 335 1.0× 260 0.8× 129 1.5k
César Rivera Chile 18 651 1.1× 428 0.7× 356 0.8× 116 0.3× 359 1.1× 66 1.7k
Diana V. Messadi United States 28 510 0.8× 531 0.9× 260 0.6× 148 0.4× 158 0.5× 55 2.0k
Zengtong Zhou China 22 579 0.9× 836 1.4× 290 0.7× 366 1.1× 264 0.8× 65 1.6k
Hideo Shigeishi Japan 23 680 1.1× 253 0.4× 237 0.5× 177 0.5× 426 1.3× 109 1.7k
Vito Carlo Alberto Caponio Italy 22 377 0.6× 212 0.4× 229 0.5× 317 0.9× 343 1.0× 112 1.5k
Anne Christine Johannessen Norway 25 476 0.8× 475 0.8× 171 0.4× 312 0.9× 273 0.8× 95 1.6k
Marco Mascitti Italy 24 384 0.6× 273 0.5× 152 0.3× 249 0.7× 308 0.9× 77 1.3k
Andrea Santarelli Italy 32 889 1.5× 410 0.7× 272 0.6× 465 1.4× 1.0k 3.0× 117 2.9k

Countries citing papers authored by Chuan‐Hang Yu

Since Specialization
Citations

This map shows the geographic impact of Chuan‐Hang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuan‐Hang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuan‐Hang Yu more than expected).

Fields of papers citing papers by Chuan‐Hang Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuan‐Hang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuan‐Hang Yu. The network helps show where Chuan‐Hang Yu may publish in the future.

Co-authorship network of co-authors of Chuan‐Hang Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Chuan‐Hang Yu. A scholar is included among the top collaborators of Chuan‐Hang Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuan‐Hang Yu. Chuan‐Hang Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Cheng‐Chia, Pei‐Ling Hsieh, Yi‐Wen Liao, et al.. (2024). Carvacrol inhibits the progression of oral submucous fibrosis via downregulation of PVT1/miR‐20a‐5p‐mediated pyroptosis. Journal of Cellular and Molecular Medicine. 28(18). e70112–e70112. 1 indexed citations
3.
Yu, Chuan‐Hang, et al.. (2023). XIST/let-7i/HMGA1 axis maintains myofibroblasts activities in oral submucous fibrosis. International Journal of Biological Macromolecules. 232. 123400–123400. 11 indexed citations
4.
Yang, Cheng‐Chieh, Cheng‐Hsien Wu, Yu-Hsien Lee, et al.. (2022). Improving the Diagnostic Performance by Adding Methylation Marker to Conventional Visual Examination in Identifying Oral Cancer. Diagnostics. 12(7). 1544–1544. 4 indexed citations
5.
Yu, Cheng‐Chia, et al.. (2022). Fenofibrate diminishes the self-renewal and metastasis potentials of oral carcinoma stem cells through NF-κB signaling. Journal of the Formosan Medical Association. 121(10). 1900–1907. 7 indexed citations
7.
Yang, Cheng‐Chieh, Chung‐Ji Liu, Cheng‐Hsien Wu, et al.. (2021). Is OLP potentially malignant? A clue from ZNF582 methylation. Oral Diseases. 29(3). 1282–1290. 6 indexed citations
8.
Liu, Chia‐Ming, Szu-Han Chen, Yi‐Wen Liao, et al.. (2021). Magnolol ameliorates the accumulation of reactive oxidative stress and inflammation in diabetic periodontitis. Journal of the Formosan Medical Association. 120(7). 1452–1458. 35 indexed citations
9.
Peng, Chih‐Yu, Cheng‐Chia Yu, Yi‐Wen Liao, et al.. (2021). Magnolol inhibits cancer stemness and IL-6/Stat3 signaling in oral carcinomas. Journal of the Formosan Medical Association. 121(1). 51–57. 28 indexed citations
10.
Lee, Yu-Hsien, et al.. (2021). Inhibition of lncRNA HOTTIP ameliorated myofibroblast activities and inflammatory cytokines in oral submucous fibrosis. Journal of the Formosan Medical Association. 120(5). 1188–1193. 15 indexed citations
11.
Lin, Taichen, Cheng‐Chia Yu, Chia‐Ming Liu, et al.. (2020). Er:YAG laser promotes proliferation and wound healing capacity of human periodontal ligament fibroblasts through Galectin-7 induction. Journal of the Formosan Medical Association. 120(1). 388–394. 22 indexed citations
12.
Lin, Taichen, Cheng‐Chia Yu, Yi‐Wen Liao, et al.. (2020). miR-200a inhibits proliferation rate in drug-induced gingival overgrowth through targeting ZEB2. Journal of the Formosan Medical Association. 119(8). 1299–1305. 4 indexed citations
13.
Lu, Ming‐Yi, Cheng‐Chia Yu, Pei‐Yin Chen, et al.. (2018). miR-200c inhibits the arecoline-associated myofibroblastic transdifferentiation in buccal mucosal fibroblasts. Journal of the Formosan Medical Association. 117(9). 791–797. 30 indexed citations
14.
Lin, Taichen, Cheng‐Chia Yu, Pei‐Ling Hsieh, et al.. (2018). Down-regulation of miR-200b-targeting Slug axis by cyclosporine A in human gingival fibroblasts. Journal of the Formosan Medical Association. 117(12). 1072–1077. 9 indexed citations
16.
Hu, Fang‐Wei, Lo‐Lin Tsai, Chuan‐Hang Yu, et al.. (2012). Impairment of tumor‐initiating stem‐like property and reversal of epithelial–mesenchymal transdifferentiation in head and neck cancer by resveratrol treatment. Molecular Nutrition & Food Research. 56(8). 1247–1258. 89 indexed citations
17.
Lin, Yen‐Hung, Chuan‐Hang Yu, Chia-Chuan Chang, et al.. (2008). Expression of p34(superscript cdc2) in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma. Journal of Dental Sciences. 3(3). 125–132. 1 indexed citations
18.
Yu, Chuan‐Hang, Jeng‐Tzung Wang, Bu-Yuan Liu, et al.. (2007). Nuclear expression of metastasis-associated protein 1 (MTA1) is inversely related to progression of oral squamous cell carcinoma in Taiwan. Journal of Dental Sciences. 2(1). 1–10. 7 indexed citations
19.
Lee, Jang‐Jaer, Hsin-Chia Hung, Shih‐Jung Cheng, et al.. (2007). Factors associated with underdiagnosis from incisional biopsy of oral leukoplakic lesions. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology. 104(2). 217–225. 67 indexed citations
20.
Yu, Chuan‐Hang, Jeng‐Tzung Wang, Yi‐Ping Wang, et al.. (2005). Oral Nevi-A Clinicopathological Study of 29 Cases. Journal of Dental Sciences. 24(1). 50–58. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026